[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Hims & Hers Health, Inc. (HIMS) reporting a proposed sale of Class A common stock. The notice identifies a proposed sale of 175,661 Class A shares through Fidelity Brokerage Services LLC with an aggregate market value of $9,384,625.88 and lists 217,641,958 shares outstanding. The filing shows acquisition dates for the shares to be sold: restricted stock vesting on 03/15/2022, 03/15/2023, 06/15/2023, and 06/15/2024 (totaling listed smaller lots), and an option grant payable in cash on 09/16/2025 for 125,335 shares. The approximate date of sale is 09/16/2025 on the NYSE. The filing also discloses multiple sales by the seller(s) during the past three months with amounts and gross proceeds for each transaction. The form includes the required signature representation about material nonpublic information.

Insights

Securities Analyst

TL;DR: Insider notice reports a scheduled sale of 175,661 Class A shares valued at $9.38M, plus recent monthly dispositions disclosed.

This Form 144 shows a planned sale routed through Fidelity and documents the provenance of the shares as mostly vested restricted stock and an option exercise dated 09/16/2025 payable in cash. The filing also catalogs a series of sales by the same holder(s) over the prior three months with stated gross proceeds per trade, which provides market transparency on recent liquidity events by the holder(s).

Corporate Governance Expert

TL;DR: The filing is a standard insider disclosure noting planned sales and vesting history; it fulfills Rule 144 notice requirements.

The document supplies the necessary details under Rule 144: broker, number of shares, market value, acquisition dates and nature (restricted stock vesting and option grant), and a representation regarding material nonpublic information. It documents both proposed future sales and completed transactions in the prior three months, supporting transparency for shareholders and regulators.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	175661	9384625.88	217641958	09/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	03/15/2022	Restricted Stock Vesting	Issuer			13178	03/15/2022	Compensation
Class A	03/15/2023	Restricted Stock Vesting	Issuer			26063	03/15/2023	Compensation
Class A	06/15/2023	Restricted Stock Vesting	Issuer			8293	06/15/2023	Compensation
Class A	06/15/2024	Restricted Stock Vesting	Issuer			2792	06/15/2024	Compensation
Class A	09/16/2025	Option Granted - 06/17/2020	Issuer			125335	09/16/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	128127	7230644.74
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	47534	2686298.76
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	65110	3855543.59
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	2792	141216.51
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/16/2025	47534	2388816.19
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/21/2025	125335	6208636.66
Andrew Dudum 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/18/2025	128127	5773247.84
Dudum Family Community Property Trust Dtd 03/04/21 2269 Chestnut Street #523 San Francisco CA 94123	Class A	08/18/2025	47534	2141494.49

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)